BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin L, Lu W, Dai T, Chen H, Wang T, Yang L, Yang X, Liu Y, Sun D. Novel artemisinin derivatives with potent anticancer activities and the anti-colorectal cancer effect by the mitochondria-mediated pathway. Bioorg Chem 2021;106:104496. [PMID: 33288320 DOI: 10.1016/j.bioorg.2020.104496] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Jin P, Jiang J, Zhou L, Huang Z, Nice EC, Huang C, Fu L. Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management. J Hematol Oncol 2022;15:97. [PMID: 35851420 DOI: 10.1186/s13045-022-01313-4] [Reference Citation Analysis]
2 Zhang S, Yi C, Li WW, Luo Y, Wu YZ, Ling HB. The current scenario on anticancer activity of artemisinin metal complexes, hybrids, and dimers. Arch Pharm (Weinheim) 2022;:e2200086. [PMID: 35484335 DOI: 10.1002/ardp.202200086] [Reference Citation Analysis]
3 Zhang R, Zhang Y, Tang L, Xu Y, Li H, Jiang X, Xin X, Gui Z. Ptxplatin: a multifunctional Pt( iv ) antitumor prodrug. Inorg Chem Front . [DOI: 10.1039/d2qi01398c] [Reference Citation Analysis]
4 Xu C, Shao T, Shao S, Jin G. High activity, high selectivity and high biocompatibility BODIPY-pyrimidine derivatives for fluorescence target recognition and evaluation of inhibitory activity. Bioorg Chem 2021;114:105121. [PMID: 34214754 DOI: 10.1016/j.bioorg.2021.105121] [Reference Citation Analysis]